Resources for Granuflo Victims and Their Families
· Granuflo Lawsuits Could See Consolidation · FDA Issues GranuFlo Recall · A Class I Recall of Granuflo is Issued · GranuFlo and NaturaLyte Heart Attack Risk · Questions and Answers About Frensenius and its Dialysis Products GranuFlo and NaturaLyte If you have questions about a potential GranuFlo case — that is, if you or […]
Low Doses of Risperdal Do Not Lead to Gynecomastia?
Here is another compelling article from the literature: “Risperidone induced symptomatic hyperprolactinemia in adolescents” from the Journal of Clinical Psychopharmacology, April 2006, Volume 26, Issue 2, Pages 167 and 171. In the abstract, the authors noted: “Studies performed in adult patients unambiguously demonstrate a marked effect of risperidone on prolactin blood levels, with possible clinical […]
Authorities Outraged By Sloppy Statin Science
Fiona Godlee, the editor of the British Medical Journal — one of the most respected medical journals in the world — put the problem bluntly: “there is a concern underlying [the authors’] critique that will be familiar to BMJ readers. It is that all of the trials included in the CTT meta-analysis were funded by […]
Chapter 14: Where to Go from Here?
The GranuFlo disaster is awful, but hope springs eternal. For the friends and family members of patients who died (or suffered injury) from alkalosis or other dialysis side effects, the pain may never go away. But the wheels of justice are turning. Fresenius’ misdeeds have finally caught up with the company. FMC is currently […]
Another Disturbing Study about Risperdal and Gynecomastia
Here is another very thought provoking article, “Drug-induced gynecomastia: an evidence-based review,” published in Expert Opinion Drug Safety. The authors noted that: “Drugs are estimated to cause about 10 – 25% of all cases of gynecomastia. Over the course of several decades, multiple medications have been implicated in the development of gynecomastia, mostly in the […]
The Cochrane Collaboration’s New Line on Statins: What Does It All Mean?
Let us take a step back and consider our recent discussion about statin science in context. At the risk of being repetitious… the Cochrane Collaboration is considered by many to be the equivalent of the Supreme Court of science. Yet the authors of the 2013 statin meta-analysis used another group’s sloppy work, incorrectly assessed […]
Chapter 13: A Call to Action
The sheer size and scope of the GranuFlo disaster is difficult to comprehend. On some level, Fresenius’s gruesome, cynical calculus makes sense. The company, after all, brings in 64% of its annual global revenue of $12.8 billion from its North American dialysis clinics. GranuFlo is one of the most profitable products in its dialysis arsenal. […]
The Indirect Costs of Gynecomastia
Experts now believe that up to 25% of cases of gynecomastia may be caused by drug side effects. In addition to swelling breast tissue, adolescent males and men may experience pain in their breasts, discharge from their nipples, and tenderness. The true costs of these side effects cannot be measured simply in terms of medical […]
The Cochrane Collaboration’s Skeptical Look at the Efficacy of Statins
Authors Ebrahim and colleagues also noted in their Cochrane editorial about statin research that: “There are a number of concerning points with this review that arise due to limitations in the published data. First, in the majority of trials in the review… calculations were based on composite outcomes; second, in over one third of trials […]
What Causes Nasty VLDL Cholesterol [High Carbohydrate Diets?]
Gary Taubes — and many other people who have studied lipid biochemistry — point out that if VLDL specifically (not LDL in general) could be a primary villain in heart disease, effort should probably be put towards identifying what causes the formation of the VLDL particles and what oxidizes them. Taubes blames diets rich in […]